Invesco Ltd. 13D and 13G filings for Halozyme Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-01 3:51 pm Sale |
2024-02-01 | 13G | Halozyme Therapeutics, Inc. HALO |
Invesco Ltd. IVZ |
2,816,427 2.100% |
-4,220,524 (-59.98%) |
Filing |
| 2023-02-09 6:35 pm Purchase |
2023-02-08 | 13G | Halozyme Therapeutics, Inc. HALO |
Invesco Ltd. IVZ |
7,036,951 5.200% |
7,036,951 (New Position) |
Filing |